11 results on '"Koralov, Sergei B."'
Search Results
2. miRNAs in B Cell Development and Lymphomagenesis.
- Author
-
Coffre, Maryaline and Koralov, Sergei B.
- Subjects
- *
HEMATOLOGIC malignancies , *MICRORNA , *B cells , *IMMUNE response , *NON-coding RNA , *GENETICS , *PHYSIOLOGY - Abstract
B lymphocytes are essential for an efficient immune response against a variety of pathogens. A large fraction of hematologic malignancies is of B cell origin, suggesting that the development and activation of B cells need to be tightly regulated. In recent years, increasing evidence has emerged demonstrating that microRNAs (miRNAs) – a class of non-coding RNAs that control gene expression – are involved in the regulation of B cell development and function. We provide here an overview of the current knowledge on the role of miRNAs and their relevant targets in B cell development, B cell activation, and B cell malignant transformation. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
3. miRNAs Are Essential for the Regulation of the PI3K/AKT/FOXO Pathway and Receptor Editing during B Cell Maturation.
- Author
-
Coffre, Maryaline, Benhamou, David, Rieß, David, Blumenberg, Lili, Snetkova, Valentina, Hines, Marcus J., Chakraborty, Tirtha, Bajwa, Sofia, Jensen, Kari, Chong, Mark M.W., Getu, Lelise, Silverman, Gregg J., Blelloch, Robert, Littman, Dan R., Calado, Dinis, Melamed, Doron, Skok, Jane A., Rajewsky, Klaus, and Koralov, Sergei B.
- Abstract
Summary B cell development is a tightly regulated process dependent on sequential rearrangements of immunoglobulin loci that encode the antigen receptor. To elucidate the role of microRNAs (miRNAs) in the orchestration of B cell development, we ablated all miRNAs at the earliest stage of B cell development by conditionally targeting the enzymes critical for RNAi in early B cell precursors. Absence of any one of these enzymes led to a block at the pro- to pre-B cell transition due to increased apoptosis and a failure of pre-B cells to proliferate. Expression of a Bcl2 transgene allowed for partial rescue of B cell development, however, the majority of the rescued B cells had low surface immunoglobulin expression with evidence of ongoing light chain editing. Our analysis revealed that miRNAs are critical for the regulation of the PTEN-AKT-FOXO1 pathway that in turn controls Rag expression during B cell development. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
4. Tyk2 and Stat3 Regulate Brown Adipose Tissue Differentiation and Obesity.
- Author
-
Derecka, Marta, Gornicka, Agnieszka, Koralov, Sergei B., Szczepanek, Karol, Morgan, Magdalena, Raje, Vidisha, Sisler, Jennifer, Zhang, Qifang, Otero, Dennis, Cichy, Joanna, Rajewsky, Klaus, Shimoda, Kazuya, Poli, Valeria, Strobl, Birgit, Pellegrini, Sandra, Harris, Thurl E., Seale, Patrick, Russell, Aaron P., McAinch, Andrew J., and O’Brien, Paul E.
- Subjects
CELL differentiation ,BROWN adipose tissue ,PROTEIN-tyrosine kinases ,CELLULAR signal transduction ,TRANSCRIPTION factors ,OBESITY ,SKELETAL muscle ,TRANSGENE expression - Abstract
Summary: Mice lacking the Jak tyrosine kinase member Tyk2 become progressively obese due to aberrant development of Myf5+ brown adipose tissue (BAT). Tyk2 RNA levels in BAT and skeletal muscle, which shares a common progenitor with BAT, are dramatically decreased in mice placed on a high-fat diet and in obese humans. Expression of Tyk2 or the constitutively active form of the transcription factor Stat3 (CAStat3) restores differentiation in Tyk2
−/− brown preadipocytes. Furthermore, Tyk2−/− mice expressing CAStat3 transgene in BAT also show improved BAT development, normal levels of insulin, and significantly lower body weights. Stat3 binds to PRDM16, a master regulator of BAT differentiation, and enhances the stability of PRDM16 protein. These results define Tyk2 and Stat3 as critical determinants of brown fat lineage and suggest that altered levels of Tyk2 are associated with obesity in both rodents and humans. [ABSTRACT FROM AUTHOR]- Published
- 2012
- Full Text
- View/download PDF
5. Activation of Stat3 Signaling in AgRP Neurons Promotes Locomotor Activity.
- Author
-
Mesaros, Andrea, Koralov, Sergei B., Rother, Eva, Wunderlich, F. Thomas, Ernst, Marianne B., Barsh, Gregory S., Rajewsky, Klaus, and Brüning, Jens C.
- Subjects
LEPTIN ,PEPTIDES ,HUMAN locomotion - Abstract
Summary: Leptin, an adipocyte-derived hormone, acts on hypothalamic neurons located in the arcuate nucleus (ARC) of the hypothalamus to regulate energy homeostasis. One of the leptin-regulated neuronal subtypes in the ARC are agouti-related peptide (AgRP)-expressing neurons, which are involved in the regulation of food intake and are directly inhibited by leptin. Leptin activates the signal transducer and activator of transcription 3 (Stat3), but the role of Stat3 in the regulation of AgRP neurons is unclear. Here we show that mice expressing a constitutively active version of Stat3 selectively in AgRP neurons are lean and exhibit relative resistance to diet-induced obesity. Surprisingly, this phenotype arises from increased locomotor activity in the presence of unaltered AgRP expression. These data demonstrate that Stat3-dependent signaling in AgRP neurons in the ARC controls locomotor activity independently of AgRP regulation. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
6. Mitochondrial Oxidative Phosphorylation Regulates the Fate Decision between Pathogenic Th17 and Regulatory T Cells.
- Author
-
Shin, Boyoung, Benavides, Gloria A., Geng, Jianlin, Koralov, Sergei B., Hu, Hui, Darley-Usmar, Victor M., and Harrington, Laurie E.
- Abstract
Understanding metabolic pathways that regulate Th17 development is important to broaden therapeutic options for Th17-mediated autoimmunity. Here, we report a pivotal role of mitochondrial oxidative phosphorylation (OXPHOS) for lineage specification toward pathogenic Th17 differentiation. Th17 cells rapidly increase mitochondrial respiration during development, and this is necessary for metabolic reprogramming following T cell activation. Surprisingly, specific inhibition of mitochondrial ATP synthase ablates Th17 pathogenicity in a mouse model of autoimmunity by preventing Th17 pathogenic signature gene expression. Notably, cells activated under OXPHOS-inhibited Th17 conditions preferentially express Foxp3, rather than Th17 genes, and become suppressive Treg cells. Mechanistically, OXPHOS promotes the Th17 pioneer transcription factor, BATF, and facilitates T cell receptor (TCR) and mTOR signaling. Correspondingly, overexpression of BATF rescues Th17 development when ATP synthase activity is restricted. Together, our data reveal a regulatory role of mitochondrial OXPHOS in dictating the fate decision between Th17 and Treg cells by supporting early molecular events necessary for Th17 commitment. • CD4 T cells rapidly increase mitochondrial respiration during Th17 differentiation • OXPHOS is essential for Th17 cell pathogenicity in a mouse model of MS • Mitochondrial respiration shapes the Th17 and Treg cell fate decision • OXPHOS facilitates TCR and mTOR signaling, which in turn support BATF induction Shin et al. report that ATP-linked mitochondrial respiration controls the Th17 and Treg cell fate decision by supporting TCR signaling and Th17-associated molecular events. Inhibition of mitochondrial OXPHOS ablates Th17 pathogenicity in a mouse model of MS and results in generation of functionally suppressive Treg cells under Th17 conditions. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
7. Activation of Oxidative Stress Response in Cancer Generates a Druggable Dependency on Exogenous Non-essential Amino Acids.
- Author
-
LeBoeuf, Sarah E., Wu, Warren L., Karakousi, Triantafyllia R., Karadal, Burcu, Jackson, S. RaElle, Davidson, Shawn M., Wong, Kwok-Kin, Koralov, Sergei B., Sayin, Volkan I., and Papagiannakopoulos, Thales
- Abstract
Rewiring of metabolic pathways is a hallmark of tumorigenesis as cancer cells acquire novel nutrient dependencies to support oncogenic growth. A major genetic subtype of lung adenocarcinoma with KEAP1 / NRF2 mutations, which activates the endogenous oxidative stress response, undergoes significant metabolic rewiring to support enhanced antioxidant production. We demonstrate that cancers with high antioxidant capacity exhibit a general dependency on exogenous non-essential amino acids (NEAAs) that is driven by the Nrf2-dependent secretion of glutamate through system x c
− (XCT), which limits intracellular glutamate pools that are required for NEAA synthesis. This dependency can be therapeutically targeted by dietary restriction or enzymatic depletion of individual NEAAs. Importantly, limiting endogenous glutamate levels by glutaminase inhibition can sensitize tumors without alterations in the Keap1/Nrf2 pathway to dietary restriction of NEAAs. Our findings identify a metabolic strategy to therapeutically target cancers with genetic or pharmacologic activation of the Nrf2 antioxidant response pathway by restricting exogenous sources of NEAAs. • Keap1 mutations drive non-essential amino acid (NEAA) dependency in cancer • Intracellular glutamate levels dictate cellular ability to survive NEAA deprivation • Restriction of NEAA can suppress Keap1 mutant tumor growth in vivo • Limiting glutamate by glutaminase inhibition enhances response to NEAA deprivation LeBoeuf et al. describe a general mechanism through which cancer cells depend on non-essential amino acids. Tumor cells with intrinsically low intracellular glutamate require amino acids to be supplied from the extracellular environment. By reducing the amount of circulating amino acids, the authors reduce tumor growth in vivo. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
8. Calcium Signaling Controls Pathogenic Th17 Cell-Mediated Inflammation by Regulating Mitochondrial Function.
- Author
-
Kaufmann, Ulrike, Kahlfuss, Sascha, Yang, Jun, Ivanova, Elitza, Koralov, Sergei B., and Feske, Stefan
- Abstract
Pathogenic Th17 cells play important roles in many autoimmune and inflammatory diseases. Their function depends on T cell receptor (TCR) signaling and cytokines that activate signal transducer and activator of transcription 3 (STAT3). TCR engagement activates stromal interaction molecule 1 (STIM1) and calcium (Ca
2+ ) influx through Ca2+ -release-activated Ca2+ (CRAC) channels. Here, we show that abolishing STIM1 and Ca2+ influx in T cells expressing a hyperactive form of STAT3 (STAT3C) attenuates pathogenic Th17 cell function and inflammation associated with STAT3C expression. Deletion of STIM1 in pathogenic Th17 cells reduces the expression of genes required for mitochondrial function and oxidative phosphorylation (OXPHOS) but enhances reactive oxygen species (ROS) production. STIM1 deletion or inhibition of OXPHOS is associated with a non-pathogenic Th17 gene expression signature and impaired pathogenic Th17 cell function. Our findings establish Ca2+ influx as a critical regulator of mitochondrial function and oxidative stress in pathogenic Th17 cell-mediated multiorgan inflammation. • STIM1-mediated calcium flux controls ETC expression in pathogenic Th17 cells • STIM1 deficiency impairs OXPHOS and increases mROS in Th17 cells • Loss of STIM1 and OXPHOS inhibition results in a non-pathogenic Th17 gene signature • Lack of STIM1 protects from Th17 cell-mediated lung, intestinal, and skin inflammation Kaufmann et al. show an essential role of the store-operated calcium entry (SOCE) pathway in pathogenic Th17 cell function by regulating mitochondrial function and OXPHOS, and preventing oxidative stress. SOCE inhibition could be a potential therapeutic avenue in Th17 inflammatory diseases such as MS, colitis, psoriasis, or steroid-resistant asthma. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
9. Distinct Requirements of CHD4 during B Cell Development and Antibody Response.
- Author
-
Yen, Wei-Feng, Sharma, Rahul, Cols, Montserrat, Lau, Colleen M., Chaudhry, Ashutosh, Chowdhury, Priyanka, Yewdell, William T., Vaidyanathan, Bharat, Sun, Amy, Coffre, Maryaline, Pucella, Joseph N., Chen, Chun-Chin, Jasin, Maria, Sun, Joseph C., Rudensky, Alexander Y., Koralov, Sergei B., and Chaudhuri, Jayanta
- Abstract
The immunoglobulin heavy chain (Igh) locus features a dynamic chromatin landscape to promote class switch recombination (CSR), yet the mechanisms that regulate this landscape remain poorly understood. CHD4, a component of the chromatin remodeling NuRD complex, directly binds H3K9me3, an epigenetic mark present at the Igh locus during CSR. We find that CHD4 is essential for early B cell development but is dispensable for the homeostatic maintenance of mature, naive B cells. However, loss of CHD4 in mature B cells impairs CSR because of suboptimal targeting of AID to the Igh locus. Additionally, we find that CHD4 represses p53 expression to promote B cell proliferation. This work reveals distinct roles for CHD4 in B cell development and CSR and links the H3K9me3 epigenetic mark with AID recruitment to the Igh locus. • CHD4 is essential for early B cell development • Naive, mature B cells can sustain loss of CHD4 • CHD4 represses p53 expression and promotes B cell proliferation • Loss of CHD4 influences recruitment of AID to the Igh locus and impairs CSR Yen et al. demonstrate that CHD4, a component of the NuRD remodeling complex, is essential for early B cell development, represses p53 expression in mature B cells, and influences the recruitment of AID to DNA during class switch recombination. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
10. Impaired Expression of Rearranged Immunoglobulin Genes and Premature p53 Activation Block B Cell Development in BMI1 Null Mice.
- Author
-
Cantor, David J., King, Bryan, Blumenberg, Lili, DiMauro, Teresa, Aifantis, Iannis, Koralov, Sergei B., Skok, Jane A., and David, Gregory
- Abstract
Summary B cell development is a highly regulated process that requires stepwise rearrangement of immunoglobulin genes to generate a functional B cell receptor (BCR). The polycomb group protein BMI1 is required for B cell development, but its function in developing B cells remains poorly defined. We demonstrate that BMI1 functions in a cell-autonomous manner at two stages during early B cell development. First, loss of BMI1 results in a differentiation block at the pro-B cell to pre-B cell transition due to the inability of BMI1-deficient cells to transcribe newly rearranged Igh genes. Accordingly, introduction of a pre-rearranged Igh allele partially restored B cell development in Bmi1
−/− mice. In addition, BMI1 is required to prevent premature p53 signaling, and as a consequence, Bmi1−/− large pre-B cells fail to properly proliferate. Altogether, our results clarify the role of BMI1 in early B cell development and uncover an unexpected function of BMI1 during VDJ recombination. Graphical Abstract Highlights • BMI1 is required at the pro-B cell to pre-B cell transition in a cell-autonomous manner • BMI1 promotes the expression of newly rearranged Igh genes in pro-B cells • BMI1 prevents premature p53 activation and enables large pre-B cell proliferation Cantor et al. identify a cell-autonomous role for the polycomb group protein BMI1 in early B cell development. At the pro-B cell to pre-B cell transition, BMI1 promotes the expression of newly rearranged Igh genes in pro-B cells and subsequently prevents premature p53 activation and enables large pre-B cell proliferation. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
11. Limited miR-17-92 overexpression drives hematologic malignancies.
- Author
-
Danielson, Laura S., Reavie, Linsey, Coussens, Marc, Davalos, Veronica, Castillo-Martin, Mireia, Guijarro, Maria V., Coffre, Maryaline, Cordon-Cardo, Carlos, Aifantis, Iannis, Ibrahim, Sherif, Liu, Cynthia, Koralov, Sergei B., and Hernando, Eva
- Subjects
- *
NEOPLASTIC cell transformation , *MICRORNA , *GENETIC overexpression , *HEMATOLOGIC malignancies , *LYMPHOMAS , *DEVELOPMENTAL disabilities - Abstract
The overexpression of microRNA cluster miR-17-92 has been implicated in development of solid tumors and hematological malignancies. The role of miR-17-92 in lymphomagenesis has been extensively investigated; however, because of the developmental defects caused by miR-17-92 dysregulation, its ability to drive tumorigenesis has remained undetermined until recently. Here we demonstrate that overexpression of miR-17-92 in a limited number of hematopoietic cells is sufficient to cause B cell malignancies. In sum, our study provides a novel and physiologically relevant model that exposes the potent ability of miR-17-92 to act as a driver of tumorigenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.